GNH USA

Europe — EMA

Laevolac Pflaumenaroma

GNH USA supplies Laevolac Pflaumenaroma (Lactulose), a osmotic laxative for constipation and hepatic encephalopathy. Request a quote for global supply.

Lactulose, Liquid

Request sourcing

1
Pack/s

What is Lactulose, Liquid?

Lactulose, the active ingredient in Laevolac Pflaumenaroma, is an osmotic laxative presented as a liquid oral solution for oral use. It works by drawing water into the bowel to soften stools and by lowering colonic pH, which helps manage constipation and reduces ammonia absorption in hepatic encephalopathy.

GNH USA supplies Laevolac Pflaumenaroma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured medicines across global markets. The company adheres to stringent quality standards and offers comprehensive logistics support for timely delivery.

What is Lactulose, Liquid used for?

Lactulose is an osmotic laxative used to manage conditions related to bowel transit and ammonia accumulation.

- Constipation: softens stool and promotes regular bowel movements. - Hepatic encephalopathy: lowers colonic ammonia production to improve neurological symptoms. - Prevention of hepatic encephalopathy recurrence: maintains low ammonia levels to reduce the risk of episodic deterioration.

What are the side effects of Lactulose, Liquid?

Lactulose may cause a range of adverse reactions, most of which are related to its osmotic activity in the gut.

Common Side Effects: - Bloating: sensation of abdominal fullness. - Flatulence: increased intestinal gas. - Abdominal cramps: mild to moderate discomfort. - Diarrhea: loose stools, especially at higher doses. - Nausea: feeling of sickness. - Electrolyte imbalance: mild disturbances in sodium or potassium.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss requiring medical attention. - Electrolyte disturbances: significant hyponatremia or hypokalemia. - Allergic reaction: rash, itching, or swelling. - Severe abdominal pain: persistent or worsening pain. - Hypotension: low blood pressure due to fluid shifts.

What precautions apply to Lactulose, Liquid?

Before initiating lactulose therapy, consider the following precautions.

- Renal function assessment: evaluate kidney status as fluid shifts may affect renal clearance. - Electrolyte monitoring: check serum electrolytes, especially with prolonged use. - Diabetes caution: monitor blood glucose as lactulose can affect carbohydrate metabolism. - Avoid abrupt discontinuation: taper dose to prevent rebound constipation. - Hepatic impairment dose adjustment: use the lowest effective dose in severe liver disease. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

What does Lactulose, Liquid interact with?

Lactulose can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: may reduce lactulose's osmotic effect. - Oral antibiotics: can alter gut flora, affecting lactulose metabolism. - Phosphate binders: may interfere with lactulose activity.

Moderate Interactions (Monitor Closely): - Diabetes medications: monitor blood glucose as lactulose may affect glucose absorption. - Loop diuretics: watch for electrolyte disturbances. - Probiotics: may increase gas production and abdominal discomfort.

Frequently asked questions

What is Laevolac Pflaumenaroma used for?+
Laevolac Pflaumenaroma contains lactulose, an osmotic laxative indicated for the treatment of constipation and for the management of hepatic encephalopathy, where it helps lower ammonia levels in the gut.
How does lactulose work?+
Lactulose is not absorbed in the small intestine; in the colon it is broken down by bacteria into short‑chain acids. This creates an osmotic gradient that draws water into the bowel, softening stool, and the acidic environment converts ammonia to ammonium, reducing its absorption.
What is the usual dose of Laevolac Pflaumenaroma?+
The prescribed dose of lactulose is individualized by the treating clinician based on the patient’s condition, response, and tolerance. The healthcare professional determines the volume and frequency appropriate for constipation or hepatic encephalopathy.
Is Laevolac Pflaumenaroma safe in pregnancy or breastfeeding?+
Safety data for lactulose during pregnancy and lactation are limited. It should only be used when the potential benefit outweighs any possible risk, and the decision should be made in consultation with a qualified healthcare provider.
How do I order Laevolac Pflaumenaroma from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Laevolac Pflaumenaroma compare with other laxatives?+
Lactulose is an osmotic laxative, differing from stimulant laxatives that increase intestinal motility. Osmotic agents like lactulose draw water into the colon, offering a gentler, often better‑tolerated option for chronic constipation and also provide the added benefit of reducing ammonia in hepatic encephalopathy.
How should Laevolac Pflaumenaroma be stored and handled?+
Store the oral solution at room temperature, below 25 °C, in its original container. Protect it from moisture and direct sunlight. Keep the bottle tightly closed when not in use to maintain stability.
How is Laevolac Pflaumenaroma administered?+
The product is taken orally as a liquid solution. The prescribed volume is measured with a calibrated device, such as a dosing cup or syringe, and can be swallowed directly or mixed with a small amount of water or juice for easier ingestion.
What are the most serious risks associated with Laevolac Pflaumenaroma?+
Serious risks include severe dehydration, significant electrolyte disturbances (especially low sodium or potassium), and rare allergic reactions. Patients should seek medical attention if they experience persistent diarrhea, dizziness, fainting, or signs of an allergic response.
Who should not use Laevolac Pflaumenaroma?+
Lactulose should be avoided in individuals with known hypersensitivity to lactulose, those with intestinal obstruction, severe renal impairment, or in patients where rapid fluid shifts could be hazardous. A healthcare professional should evaluate suitability before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Lactulose, Liquid
Route
Oral Use
Manufacturer
Fresenius Kabi Austria Gmbh
Origin
EU

Related products